Skip to content
10-K

Annual Report

RESOLUTE ONCOLOGY INC

0001038838-13-000123

← back to feed
Filed
Mar 28, 2013 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 18, 2013 40.39M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$21.57K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$73.85K
Operating Cash Flow FY 2012 · Dec 31, 2011 −$14.5K
Cash And Equivalents FY 2012 · Dec 31, 2012 $1.08M
Cash And Equivalents FY 2012 · Dec 31, 2011 $2.46K
Cash And Equivalents FY 2012 · Dec 31, 2010 $3.43K
Stockholders Equity FY 2012 · Dec 31, 2012 −$71.92K
Stockholders Equity FY 2012 · Dec 31, 2011 −$10.46K
Stockholders Equity FY 2012 · Dec 31, 2010 $2.81K
Stockholders Equity FY 2012 · Dec 31, 2009 $27.59K
Current Liabilities FY 2012 · Dec 31, 2012 $1.79M
Current Liabilities FY 2012 · Dec 31, 2011 $24.09K
Total Liabilities FY 2012 · Dec 31, 2012 $1.79M
Total Liabilities FY 2012 · Dec 31, 2011 $24.09K
Current Assets FY 2012 · Dec 31, 2012 $1.72M
Current Assets FY 2012 · Dec 31, 2011 $2.46K
Total Assets FY 2012 · Dec 31, 2012 $1.72M
Total Assets FY 2012 · Dec 31, 2011 $13.63K
Net Income FY 2012 · Dec 31, 2012 −$61.46K
Net Income FY 2012 · Dec 31, 2012 −$106.92K
Net Income FY 2012 · Dec 31, 2011 −$13.27K
Net Income FY 2012 · Dec 31, 2010 −$29.79K
Net Income FY 2012 · Dec 31, 2009 −$2.41K
Operating Income FY 2012 · Dec 31, 2012 −$60.32K
Operating Income FY 2012 · Dec 31, 2012 −$105.79K
Operating Income FY 2012 · Dec 31, 2011 −$13.27K